focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.60
High: 0.00
Low: 0.00
Prev. Close: 0.60
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Provexis plc

6 Jun 2005 17:05

AIM06 June 2005 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:Provexis plc COMPANY ADDRESS:10 Williams House Manchester Science Park Lloyd Street North Greater Manchester COMPANY POSTCODE:M15 6SE COUNTRY OF INCORPORATION:England and Wales COMPANY BUSINESS:Nutraceutical company which develops scientifically proven, proprietary, functional foods, supplements andmedical foods DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to whichit seeks admission and the number and type to be held as treasury shares):249,628,324 ordinary shares of 1p each comprising: 33,218,388 shares (Capital reorganisation of Existing Shares) 67,424,000 shares (Placing) 111,658,555 shares (Vendor consideration) 37,327,381 shares (Loans conversion) CAPITAL TO BE RAISED ON ADMISSION:£3.8 million FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Dawson Buck (Non-executive Chairman) Neville Bain (Non-executive Deputy Chairman) Stephen Franklin (Chief Executive) Stephen Moon (Commercial Director) PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUEDSHARE CAPITAL BEFORE ADMISSION: Number of ordinary Percentage of issued shares share capitalRising Stars Growth Fund 58,959,444 23.62Progeny BioVentures Limited 31,969,179 12.81ANGLE Technology Limited 29,926,464 11.99North West Equity Fund 13,514,990 5.41Rowett Research Services Limited 13,167,873 5.28 NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (G) OFTHE AIM RULES:None ANTICIPATED ACCOUNTING REFERENCE DATE:31 March EXPECTED ADMISSION DATE:23 June 2005 NAME AND ADDRESS OF NOMINATED ADVISER:Arbuthnot Securities Limited Arbuthnot House 20 Ropemaker Street London EC2Y 9AR NAME AND ADDRESS OF BROKER:Arbuthnot Securities Limited Arbuthnot House 20 Ropemaker Street London EC2Y 9AR DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH ASTATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITSSECURITIES:Arbuthnot Securities Limited Arbuthnot House 20 Ropemaker Street London EC2Y 9AR The Admission document contains full details about the applicant and the admission of itssecurities. DATE OF NOTIFICATION:6 June 2005 NEW/ UPDATE (see note):New QUOTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING:N/ATHE NAME OF THE AIM DESIGNATED MARKET UPON WHICH THE APPLICANT'S SECURITIES HAVE BEEN TRADED: THE DATE FROM WHICH THE APPLICANT'S SECURITIES HAVE BEEN SO TRADED: CONFIRMATION THAT, FOLLOWING DUE AND CAREFUL ENQUIRY, THE APPLICANT HAS ADHERED TO ANY LEGAL AND REGULATORYREQUIREMENTS INVOLVED IN HAVING ITS SECURITIES TRADED UPON SUCH A MARKET: AN ADDRESS OR WEB-SITE ADDRESS WHERE ANY DOCUMENTS OR ANNOUNCEMENTS WHICH THE APPLICANT HAS MADE PUBLIC OVER THELAST TWO YEARS (IN CONSEQUENCE OF HAVING ITS SECURITIES SO TRADED) ARE AVAILABLE: DETAILS OF THE APPLICANT'S STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE OF AN INVESTING COMPANY, DETAILSOF ITS INVESTMENT STRATEGY: A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE APPLICANT, WHICH HAS OCCURREDSINCE THE END OF THE LAST FINANCIAL PERIOD FOR WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED: A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT THE WORKING CAPITAL AVAILIABLE TOIT OF ITS GROUP WILL BE INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION: DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE AIM RULES: A BRIEF DESCRIPTION OF THE ARRANGEMENTS FOR SETTLING THE APPLICANT'S SECURITIES: A WEBSITE ADDRESS DETAILING THE RIGHTS ATTACHING TO THE APPLICANT'S SECURITIES: INFORMATION EQUIVALENT TO THAT REQUIRED FOR AN ADMISSION DOCUMENT WHICH IS NOT CURRENTLY PUBLIC: A WEBSITE ADDRESS OF A PAGE CONTAINING THE APPLICANT'S LATEST ANNUAL REPORT AND ACCOUNTS WHICH MUST HAVE AFINANCIAL YEAR END NOT MORE THEN NINE MONTHS PRIOR TO ADMISSION. THE ACCOUNTS MUST BE PREPARED ACCORDING TO UKOR US GAAP OR INTERNATIONAL ACCOUNTING STANDARDS. THE NUMBER OF EACH CLASS OF SECURITIES HELD IN TRESURY. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Nov 20167:00 amRNSStudy publication - comparison with aspirin
18th Nov 20169:46 amRNSNew Collaboration for Fruitflow
30th Sep 20163:33 pmRNSResult of AGM
15th Sep 20165:08 pmRNSDirector/PDMR Shareholding
7th Sep 20167:00 amRNSPreliminary Results
2nd Sep 201610:23 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSResults of Placing
12th Jul 20167:00 amRNSStudy Publication
29th Jun 20167:05 amRNSFunding Update
29th Jun 20167:00 amRNSProduct Launch
9th Jun 20162:29 pmRNSFunding Update
31st May 20167:00 amRNSTrading Update
11th Apr 20164:40 pmRNSSecond Price Monitoring Extn
11th Apr 20164:35 pmRNSPrice Monitoring Extension
25th Feb 20164:40 pmRNSSecond Price Monitoring Extn
25th Feb 20164:35 pmRNSPrice Monitoring Extension
19th Feb 20164:40 pmRNSSecond Price Monitoring Extn
19th Feb 20164:35 pmRNSPrice Monitoring Extension
7th Jan 20162:01 pmRNSDirector/PDMR Shareholding
22nd Dec 20157:00 amRNSHalf Yearly Report
30th Sep 20154:58 pmRNSResult of AGM
7th Sep 201510:47 amRNSAnnual Report and Notice of AGM
4th Sep 20157:00 amRNSPreliminary Results
21st Jul 20153:41 pmRNSHolding(s) in Company
3rd Jul 20157:00 amRNSPlacing of shares via Primarybid.com
29th Jun 20157:00 amRNSUpdate of Collaboration with University of Oslo
4th Jun 20157:00 amRNSEnhanced terms for Fruitflow Alliance Agreement
24th Apr 20154:35 pmRNSPrice Monitoring Extension
20th Feb 20152:34 pmRNSFruitflow - New Product Video
19th Jan 20154:40 pmRNSSecond Price Monitoring Extn
19th Jan 20154:35 pmRNSPrice Monitoring Extension
30th Dec 20147:00 amRNSHalf Yearly Report
9th Dec 20147:00 amRNSDraw Down of Funds and Issue of Equity
1st Dec 20147:00 amRNSRe-appointment to the Scientific Advisory Board
18th Nov 20147:00 amRNSCollaboration with the University of Oslo
22nd Sep 20143:38 pmRNSResult of AGM
28th Aug 20147:00 amRNSAnnual Report and Notice of AGM
21st Aug 20147:00 amRNSPreliminary Results
8th Aug 20144:40 pmRNSSecond Price Monitoring Extn
8th Aug 20144:35 pmRNSPrice Monitoring Extension
4th Aug 20147:00 amRNSNotification of Preliminary Results
23rd Apr 20147:00 amRNSDraw Down of Funds and Issue of Equity
31st Mar 20147:00 amRNSPre-Close Update
17th Feb 20147:00 amRNSChange of Registered Office
2nd Jan 20144:40 pmRNSSecond Price Monitoring Extn
2nd Jan 20144:35 pmRNSPrice Monitoring Extension
23rd Dec 20134:40 pmRNSSecond Price Monitoring Extn
23rd Dec 20134:35 pmRNSPrice Monitoring Extension
17th Dec 20137:05 amRNSHalf Yearly Report
3rd Dec 20137:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.